Comparison of Flow and Compression Properties of Four Lactose-Based Co-Processed Excipients: Cellactose
Cellactose® 80
CombiLac®
MicroceLac® 100
StarLac®
co-processed excipients
spray drying
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
16 Sep 2021
16 Sep 2021
Historique:
received:
27
07
2021
revised:
07
09
2021
accepted:
13
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
The utilization of co-processed excipients (CPEs) represents a novel approach to the preparation of orally disintegrating tablets by direct compression. Flow, consolidation, and compression properties of four lactose-based CPEs-Cellactose
Identifiants
pubmed: 34575562
pii: pharmaceutics13091486
doi: 10.3390/pharmaceutics13091486
pmc: PMC8467879
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Masarykova Univerzita
ID : MUNI/A/1574/2020
Références
AAPS PharmSciTech. 2018 Aug;19(6):2646-2657
pubmed: 29943280
J Pharm Sci. 2015 Oct;104(10):3440-50
pubmed: 26073446
Ther Deliv. 2016 Dec;7(12):827-842
pubmed: 27854180
Recent Pat Drug Deliv Formul. 2016;10(3):192-206
pubmed: 27396400
Pharm Dev Technol. 2006 Feb;11(1):111-24
pubmed: 16544915
Acta Pol Pharm. 2015 May-Jun;72(3):539-49
pubmed: 26642662
J Pharm Biomed Anal. 2018 Apr 15;152:47-56
pubmed: 29414018
Int J Pharm. 2004 Apr 15;274(1-2):131-8
pubmed: 15072789
Eur J Pharm Biopharm. 2010 Aug;75(3):425-35
pubmed: 20406685
Drug Dev Ind Pharm. 2019 Oct;45(10):1565-1589
pubmed: 31282753
AAPS PharmSciTech. 2018 Aug;19(6):2598-2609
pubmed: 29916193
Int J Pharm. 2003 Mar 26;254(2):281-6
pubmed: 12623204
J Pharm Sci. 1981 Dec;70(12):1328-30
pubmed: 7320846
Int J Pharm. 2013 Mar 25;446(1-2):6-15
pubmed: 23402976
Drug Dev Ind Pharm. 2012 Oct;38(10):1159-70
pubmed: 22966909
Ceska Slov Farm. 2019 Winter;67(5-6):175-181
pubmed: 30871322
AAPS PharmSciTech. 2018 Feb;19(2):866-880
pubmed: 29038987
AAPS PharmSciTech. 2003 Dec 15;4(4):E62
pubmed: 15198557
Int J Pharm. 2003 Feb 18;252(1-2):253-61
pubmed: 12550801
Drug Dev Ind Pharm. 1999 Aug;25(8):869-78
pubmed: 10434130
J Pharm Sci. 1972 Mar;61(3):455-9
pubmed: 5013387
Expert Opin Drug Deliv. 2009 Feb;6(2):197-208
pubmed: 19239391
AAPS PharmSciTech. 2010 Dec;11(4):1558-71
pubmed: 21052880
Indian J Pharm Sci. 2011 Jul;73(4):392-6
pubmed: 22707822
J Pharm Sci. 2005 Oct;94(10):2132-4
pubmed: 16136576
Drug Dev Ind Pharm. 2016 Dec;42(12):2078-2085
pubmed: 27277525
Eur J Pharm Sci. 1999 Aug;8(4):235-42
pubmed: 10425373
J Pharm Sci. 1976 Nov;65(11):1694-7
pubmed: 994005
J Pharm Sci. 1970 May;59(5):688-91
pubmed: 5446428
Pharm Dev Technol. 2012 Nov-Dec;17(6):747-54
pubmed: 21563986
J Pharm Pharm Sci. 2005 Apr 16;8(1):76-93
pubmed: 15946601
Biomed Res Int. 2018 Apr 19;2018:2739428
pubmed: 29850496
AAPS J. 2004;6(2):27-38
pubmed: 18465268
Biomed Res Int. 2015;2015:608435
pubmed: 26075249
Pharm Weekbl Sci. 1986 Apr 25;8(2):145-50
pubmed: 3714438
Pharm Dev Technol. 2008;13(2):165-75
pubmed: 18379907
Int J Pharm. 2017 Mar 15;519(1-2):272-286
pubmed: 28109898
J Nat Sci Biol Med. 2010 Jul;1(1):2-5
pubmed: 22096326